.png)
Agenzia Italiana del Farmaco
home
Highlights
-
10 Sep 2024
Monitoring Registers
Hepatitis C: update of 9 September 2024 concerning enrolled patients
AIFA has published the updated weekly data concerning treatments with new second-generation direct acting antiviral agents (DAAs) for chronic hepatitis C, as collected by AIFA Monitoring registries.
-
04 Sep 2024
Lists of Class A and Class H medicinal products
List of class A and H medicinal products at 15 January 2024
AIFA makes available, to healthcare professionals, a list of class A and H medicinal products dispensed by the National Health Service, sorted by active ingredient and trade name.
-
02 Sep 2024
Monitoring Registers
Hepatitis C: update of 2 September 2024 concerning enrolled patients
AIFA has published the updated weekly data concerning treatments with new second-generation direct acting antiviral agents (DAAs) for chronic hepatitis C, as collected by AIFA Monitoring registries.
-
21 Aug 2024
Clinical trials concerning medicinal products
Guideline for the classification and conduct of observational studies on medicines
The Italian Medicines Agency has published the Guideline for the classification and conduct of observational studies on medicines in line with the provisions of the Ministerial Decree of 30 November 2021 - art. 6 paragraph 3, as part of the Italian legislation to comply with the requirements of Regulation (EU) no. 536/2014.
News
21 Aug 2024
Clinical trials concerning medicinal products
Guideline on regulatory simplification and elements of decentralisation for conducting clinical trials of medicines
02 Aug 2024
Press releases
Pharmaceutical expenditure for direct purchases
28 Jun 2024
Inspections and authorisations
GMPMED Conference: registration open
01 Aug 2024
Inspections and authorisations
Simposio GCP del 6 dicembre 2024: aperte le iscrizioni
09 Sep 2024
Safety of medicinal products
Meeting highlights from the PRAC - 2-5 September 2024
09 Sep 2024
Safety of medicinal products
EMA recommends measures to minimise serious outcomes of known side effect with painkiller metamizole
FarmaciLine
Questions regarding the efficacy, safety, and availability of drugs
NUMERO VERDE
Services
Interactive OsMed - The use of medicines in Italy
An interactive consultation of data on the use of medicines in Italy in the general and regional population, described in terms of expenditure, volumes, typology
